Pinealon
Review Pinealon oxidative-stress and rat learning research alongside a small human report, its conflicting participant counts and mixed findings.
Read research profile ↗COMPOUND INDEX
Compound Index.
Understand the research.
Research questions, reported findings, and evidence limits.
78 matching profiles
PNC-27
Understand PNC-27 membrane-targeting research, leukemia models and FDA product warnings without mistaking experiments for an established cancer treatment.
Read research profile ↗Prostamax
Examine Prostamax rat prostate-culture and human-cell chromatin research without equating structural signals with proven urinary or prostate benefits.
Read research profile ↗PT-141
Review PT-141 and bremelanotide trials, the approved HSDD indication, desire and distress results, male research and important safety limits.
Read research profile ↗PT-141 + Melanotan II
Separate bremelanotide desire trials, Melanotan II erectile-response research and prescription-label cautions from evidence for the exact pairing.
Read research profile ↗Retatrutide
Review retatrutide triple agonism, published diabetes findings, 2026 obesity updates, liver research and the limits behind headline weight-loss claims.
Read research profile ↗Selank
Evaluate Selank patient comparisons, acute brain-imaging findings and animal evidence, with clear limits on equivalence, cognitive and safety claims.
Read research profile ↗Semaglutide
Review semaglutide weight-loss trials, cardiovascular and kidney outcomes, withdrawal evidence, current product indications and safety considerations.
Read research profile ↗Semax
Review Semax rehabilitation research, acute imaging and negative animal findings without confusing biomarkers with lasting cognitive or clinical benefit.
Read research profile ↗Sermorelin
Review sermorelin pediatric and adult studies, historical GEREF approvals, body-composition findings, safety observations and analogue differences.
Read research profile ↗SLU-PP-332
Read the SLU-PP-332 evidence on ERR signaling, mouse exercise capacity, metabolism and aging kidneys, with clear boundaries for human claims.
Read research profile ↗SNAP-8
Review acetyl octapeptide-3 in human microneedle product studies, distinguishing formulation results from isolated SNAP-8 efficacy and safety claims.
Read research profile ↗SS-31
Review SS-31 and elamipretide trials, negative myopathy results, the specific Forzinity approval for Barth syndrome and safety considerations.
Read research profile ↗Survodutide
Explore survodutide obesity and liver trials, primary versus adherence-assuming weight results, treatment discontinuations and current research status.
Read research profile ↗TB-500
Understand TB-500 fragment research, how it differs from full-length thymosin beta-4, clinical trial limits and the 2026 FDA assessment.
Read research profile ↗TB-500 + BPC-157
Understand why separate packaging does not establish added repair benefit, with direct combination research, human observation limits and identity checks.
Read research profile ↗Tesamorelin
Understand tesamorelin evidence for HIV-associated abdominal fat, liver research, hormone findings, safety limits and formulation differences.
Read research profile ↗Tesamorelin + Ipamorelin
Separate tesamorelin visceral-fat trial results from the unverified added benefit of ipamorelin, with clear population, endpoint and safety distinctions.
Read research profile ↗